US658436A - Insufflator. - Google Patents
Insufflator. Download PDFInfo
- Publication number
- US658436A US658436A US1826600A US1900018266A US658436A US 658436 A US658436 A US 658436A US 1826600 A US1826600 A US 1826600A US 1900018266 A US1900018266 A US 1900018266A US 658436 A US658436 A US 658436A
- Authority
- US
- United States
- Prior art keywords
- medicine
- tube
- tubes
- nostril
- nostrils
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
Description
m. 658,436. Patantad Sent. 25, 1900.
H. H. snow.
INSUFFLATOR.
(Application filed May 28, 1900.)
(No Model.)
Wz'lne ,c'glnvcnibr;
Eaf
UNITED STATES PATENT OFFICE.
HANS HENNERIGH GROTH, OF CINCINNATI, OI-IIQ.
INSUFFLATOR.
SPECIFICATION forming-part of Letters Patent No. 658,436, dated September 25, 1900.
Amhcation 5 5 2 1900, serial No. 18,266. (No model.)
To (DZ/Z whom it may concern Be it known that I, HANS HENNERIOH GROTH, a citizen of the United States, residing at Cincinnati, in the countyof Hamilton and State of Ohio, have inventedcertain new and useful Improvements in Iusufi'lators, of
which the following is a specification.
My invention relates to that class of devices usually termed insufflators.
It is the object of my invention to provide an insufflator that is simple and economical in construction, that is easily cleaned, and that is capable of directing a predetermined quantity of medicine to either nostril and a predetermined but varying quantity to both nostrils at the same time.
My device is especially serviceable in the application of powders after the throat and nasal passages have been cleaned in the treatment of disease for the purpose of applying a soothing or healing drug to the afflicted parts and may also be used for applying liquid medicines.
Myinvention consists in providing a device with which both nostrils may be treated at. the same time and by which both nostrils are practically closed to the outside air, so, that the person in blowing through myinsuffiator forces the drug therein to the innermost passages reached from the nostrils; further, in so constructing my insuffiator that a predetermined and different quantity of medicine or drug may be simultaneously blown into each nostril, and, further, in the parts and in the construction,arrangement, and combinations of parts hereinafter described and claimed.
In the drawings, Figure 1 is a perspective view of my device. Fig. 2 is an end elevation of the same with the flexible tube omitted, and Fig. 3 is a detail in section on the line w a; of Fig. 2.
I prefer to make my improved device, with the exceptionof the flexible tube, of glass, although it is obvious that other substances may be used.
My device consists, preferably, of a pair of tubes 1 1, adapted to be placed into the nostrils and of such size as to substantially fill the same, so that outside air may be excluded from the nostrils when the powder or drug is applied. The tubes 1 1 connect at a neck 2 and preferably merge into a single tube 3, adapted to have a flexible tube 4 attached thereto, terminating in a mouthpiece 5, adapt-. ed to be placed in the mouth for blowing,
therethrough. The tubes -1 l are preferably perpendicular and the tube 3 horizontal, with a slight. depression 6 between'the two for, the
more ready reception of the powder or substance to be blown into the nostrils.
In nasal diseasesit is frequently the case that a certain specified quantity of medicine 1or drug is required for one nostril, difiering from the quantity required for the other nostril. The application of the medicine is also more easily and pleasantly applied and the best results are also obtained when the medicine is applied to both nostrils simultane-,- The medicine it is necessary to ap the medicine to enter both nasal passages.
simultaneously and, if desired, in varying quantities, and the nostrils being practically closed except through the tubes causes the medicine by the force of the blowing and the position of the valves between the nose and mouth to reach the romotest nasal passages and the seat of the disease, and the mouth upon being immediately thereafter opened, with the tubes still in the nostrils, draws the medicine into the throat-passages for the cure of throat troubles,.tl1e application to nose or throat being regulated to a nicety by the relative length or force of exhalation and subsequentinhalation. In order to regulate the quantity of medicine to be received by each nostril, I provide the depression 6 with a web 7, dividing the same into two compartments 8 9, one communicating with one of the tubes 1 and the other communicating with the other of the tubes 1 and both communicating, with the mouthtube 3. Each of the nasal tubes therefore has a depression 6 between it and the inlettube 3, therebyforming twodistinct receptacles for medicine merging and extending directly and separately and without intermediate space into the inlet-tube and located below the horizontal plane of the inlet-tube.
See Fi s. 1 and 3. [he arts therefore exa p I and connectedlv therefrom; adepression be* tendingfrom the-nasal tubes 1 l to the inlettube3 form one integral piece of simple construct-ion and utile properties, the blow-tul'ie 4, con necting with theinlet-tube, being made flexible, so as to permit the mouthpiece 5 to be readily and convenient-lyplaced in; the mouth and directed to suit-able position.
In using my device the powder or medicine is introduced through the tubes 1 1 into the compartments 8 9, either in equal quantities or in varying quantities, or into bntone of the compartments, asmay be desirable for the treatment. By this construction I am enabled to regulate thequantityof and point of'application to a nieety. t
1 By appl'yinga separate tube to each nostril simultaneously, with each communicating it with the determined.quantity of medicine to be ppliedto that nostril and with both uostr simultaneously closed to the outside air, force of exhalation from, the mouth tion 'to pass throughthe tubes andcarries the powder with the current to the seat of the disease. outside air freely through one nostril while application is made only through the other,
as in old constructions, which results in inability to reach the seat of trouble.
If itis desired to introduce an equalamount ofmedicine into each nostril, an equalamount of medicine is placed in each com' nent, and the amount thus placed in each compartment is introduced into the nostril, even if the nasal passages of one nostril are more clogged than those of the other, which is not the case in old constructions, the tendency in old constructions being for the medicine to follow the course of least resistance.
My device is simple, compact, is small, and may readily be carried in the pocket, convenient for use at home or away from home.
rough the tubes and inspiration through he nose forces the exhalation and inspira- ,1
Jtwo distinct receptacles for medicine each merging and extending directly withoutinlt does not permit-breathing the tween each of the nasal tubes and theiulet tube for'the reception of medicine, and forming two distinct receptacles for medicine each merging and extending directlywlthout 1nitermediate space and separately into the inlet-tube, the above constructed into one integral piece, and a flexible blow-tube connected with the inlet tube, and constructed and arrangedtor hlbwingthroughthe tubes for forcing the-medicinein the depressioninto both nostrils simultaneously; substantially as described. t t I y 't 2. The herein-described. i nsufflator comprising'a pair of nasal tubes l,1, for taking into both nostrilssimultaneously and |nerg& ing into an inlet blow-tube i, a depression 6 between each of the nasal tubes and the inlet-tube, a web 7 in the depression for forming thetwo compart-l nents 8, 9, in thedepres= sion for the reception of medicine andeach communicating with one of th'enasal tubes and with the inlet blow-tube, and forming termediate space and separately into theinlet-tube, the above constructed into one integral piece, and a flexible blow-tubecounected with theinlet-tube, and constructed 1 and arranged for blowing through the tubes from the inlet blow-tube and forcing the medicine in each compartment separately through the nasal tube with which it communicates and for simultaneously blowing through both compartments and nasal tubes,
substantially as described.
In testimony whereof I have subscribed my name hereto in the presence of two subscribing witnesses.
HANS HENNERICH GROTH.
Witnesses:
EARLE R. PASSEL, FLORENCE BRANDES.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1826600A US658436A (en) | 1900-05-28 | 1900-05-28 | Insufflator. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1826600A US658436A (en) | 1900-05-28 | 1900-05-28 | Insufflator. |
Publications (1)
Publication Number | Publication Date |
---|---|
US658436A true US658436A (en) | 1900-09-25 |
Family
ID=2727004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US1826600A Expired - Lifetime US658436A (en) | 1900-05-28 | 1900-05-28 | Insufflator. |
Country Status (1)
Country | Link |
---|---|
US (1) | US658436A (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5046493A (en) * | 1988-02-16 | 1991-09-10 | James Kropkowski | Nasal dispenser |
US20020165482A1 (en) * | 1997-05-27 | 2002-11-07 | Erik Keldmann | Method for introducing a powdered substance into a nostril |
US20040182388A1 (en) * | 1999-03-03 | 2004-09-23 | Djupesland Per Gisle | Nasal delivery method |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
US20150013677A1 (en) * | 2012-02-24 | 2015-01-15 | Optinose As | Nasal Delivery Devices |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
USD809128S1 (en) | 2013-05-23 | 2018-01-30 | Optinose As | Nosepiece unit |
US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
US10076615B2 (en) | 2007-04-05 | 2018-09-18 | Optinose As | Nasal delivery |
US10112021B2 (en) | 2006-06-08 | 2018-10-30 | Optinose As | Intranasal administration |
US10252010B2 (en) | 2007-10-03 | 2019-04-09 | Optinose As | Nasal delivery devices |
US10286164B2 (en) | 2003-05-20 | 2019-05-14 | Optinose As | Delivery device and method |
US10398859B2 (en) | 2004-09-15 | 2019-09-03 | Optinose As | Nasal delivery devices |
US10441733B2 (en) | 2012-06-25 | 2019-10-15 | Respira Therapeutics, Inc. | Powder dispersion devices and methods |
US10525218B2 (en) | 2006-11-28 | 2020-01-07 | Optinose As | Nasal delivery devices |
US10639437B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10639438B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10722667B2 (en) | 2007-04-05 | 2020-07-28 | Optinose As | Nasal administration |
US10737045B2 (en) | 2003-08-28 | 2020-08-11 | Optinose As | Delivery devices |
US10765829B2 (en) | 2006-07-25 | 2020-09-08 | Optinose As | Delivery of gases to the nasal airway |
US10864334B2 (en) | 2006-03-23 | 2020-12-15 | Optinose As | Nasal delivery |
US11033696B2 (en) | 2012-02-24 | 2021-06-15 | Optinose As | Nasal delivery devices |
US11291626B2 (en) | 2010-09-14 | 2022-04-05 | Optinose As | Nasal delivery of oxytocin |
US11471623B2 (en) | 2012-02-21 | 2022-10-18 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
US11571531B2 (en) | 2005-02-23 | 2023-02-07 | OptiNose Inc. | Powder delivery devices |
US11707586B2 (en) | 2014-11-19 | 2023-07-25 | OptiNose Inc. | Intranasal administration |
-
1900
- 1900-05-28 US US1826600A patent/US658436A/en not_active Expired - Lifetime
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5046493A (en) * | 1988-02-16 | 1991-09-10 | James Kropkowski | Nasal dispenser |
US6811543B2 (en) * | 1997-05-27 | 2004-11-02 | Direct-Haler A/S | Method for introducing a powdered substance into a nostril |
US20020165482A1 (en) * | 1997-05-27 | 2002-11-07 | Erik Keldmann | Method for introducing a powdered substance into a nostril |
US6648848B1 (en) * | 1997-05-27 | 2003-11-18 | Direct-Haler A/S | Inhaler for powdered medicaments |
US20060219240A1 (en) * | 1999-03-03 | 2006-10-05 | Djupesland Per G | Nasal delivery device |
US20060219241A1 (en) * | 1999-03-03 | 2006-10-05 | Djupesland Per G | Nasal delivery device |
US9072857B2 (en) | 1999-03-03 | 2015-07-07 | Optinose As | Nasal delivery device |
US20060225732A1 (en) * | 1999-03-03 | 2006-10-12 | Djupesland Per G | Nasal delivery device |
US20060231094A1 (en) * | 1999-03-03 | 2006-10-19 | Djupesland Per G | Nasal delivery device |
US8327844B2 (en) | 1999-03-03 | 2012-12-11 | Optinose As | Nasal delivery method |
US8555878B2 (en) | 1999-03-03 | 2013-10-15 | Optinose As | Nasal delivery device |
US8555877B2 (en) | 1999-03-03 | 2013-10-15 | Optinose As | Nasal delivery device |
US20040182388A1 (en) * | 1999-03-03 | 2004-09-23 | Djupesland Per Gisle | Nasal delivery method |
US9119932B2 (en) | 1999-03-03 | 2015-09-01 | Optinose As | Nasal delivery device |
US10286164B2 (en) | 2003-05-20 | 2019-05-14 | Optinose As | Delivery device and method |
US10737045B2 (en) | 2003-08-28 | 2020-08-11 | Optinose As | Delivery devices |
US10398859B2 (en) | 2004-09-15 | 2019-09-03 | Optinose As | Nasal delivery devices |
US11571531B2 (en) | 2005-02-23 | 2023-02-07 | OptiNose Inc. | Powder delivery devices |
US10864334B2 (en) | 2006-03-23 | 2020-12-15 | Optinose As | Nasal delivery |
US10112021B2 (en) | 2006-06-08 | 2018-10-30 | Optinose As | Intranasal administration |
US10765829B2 (en) | 2006-07-25 | 2020-09-08 | Optinose As | Delivery of gases to the nasal airway |
US11690969B2 (en) | 2006-07-25 | 2023-07-04 | OptiNose Inc. | Delivery of gases to the nasal airway |
US10639438B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10639437B2 (en) | 2006-11-28 | 2020-05-05 | Optinose As | Delivery devices |
US10525218B2 (en) | 2006-11-28 | 2020-01-07 | Optinose As | Nasal delivery devices |
US10076615B2 (en) | 2007-04-05 | 2018-09-18 | Optinose As | Nasal delivery |
US10722667B2 (en) | 2007-04-05 | 2020-07-28 | Optinose As | Nasal administration |
US10252010B2 (en) | 2007-10-03 | 2019-04-09 | Optinose As | Nasal delivery devices |
US11602603B2 (en) | 2007-10-03 | 2023-03-14 | Optinose, Inc. | Nasal delivery devices |
US11083858B2 (en) | 2007-10-03 | 2021-08-10 | Optinose As | Nasal delivery devices |
US9492625B2 (en) | 2009-11-12 | 2016-11-15 | Stc.Unm | Dry powder inhaler with flutter dispersion member |
US11291626B2 (en) | 2010-09-14 | 2022-04-05 | Optinose As | Nasal delivery of oxytocin |
US8651104B2 (en) | 2010-12-07 | 2014-02-18 | Respira Therapeutics, Inc. | Bead-containing dry powder inhaler |
US8561609B2 (en) | 2010-12-07 | 2013-10-22 | Respira Therapeutics, Inc. | Dry powder inhaler |
US9949923B2 (en) | 2011-03-15 | 2018-04-24 | Optinose As | Nasal delivery |
US11471623B2 (en) | 2012-02-21 | 2022-10-18 | Respira Therapeutics, Inc. | Powder dispersion methods and devices |
US20150013677A1 (en) * | 2012-02-24 | 2015-01-15 | Optinose As | Nasal Delivery Devices |
US11033696B2 (en) | 2012-02-24 | 2021-06-15 | Optinose As | Nasal delivery devices |
US10076614B2 (en) * | 2012-02-24 | 2018-09-18 | Optinose As | Nasal delivery devices |
US10441733B2 (en) | 2012-06-25 | 2019-10-15 | Respira Therapeutics, Inc. | Powder dispersion devices and methods |
USD809128S1 (en) | 2013-05-23 | 2018-01-30 | Optinose As | Nosepiece unit |
US11707586B2 (en) | 2014-11-19 | 2023-07-25 | OptiNose Inc. | Intranasal administration |
US11730904B2 (en) | 2014-11-19 | 2023-08-22 | Optinose, Inc. | Intranasal administration |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US658436A (en) | Insufflator. | |
US443191A (en) | Karl illing | |
US5727542A (en) | General purpose aerosol inhalation apparatus | |
US746749A (en) | Nasal medicator. | |
US7712466B2 (en) | Intra-oral nebulizer | |
US5036847A (en) | Breathing aid | |
US4261354A (en) | Inhalator-breathing apparatus | |
EP0050654B1 (en) | Inhalation spirometric device for administering pulmonary medication | |
US4262666A (en) | Inhalator-breathing apparatus | |
NO332022B1 (en) | Powder Inhalation Device | |
US794641A (en) | Inhaler. | |
US419942A (en) | Insufflator | |
EP3484562B1 (en) | Atomizer unit comprising a replaceable mouthpiece | |
US1155608A (en) | Inhaler. | |
US598286A (en) | Inhaler | |
US533127A (en) | Inhaler and respirator | |
US1105934A (en) | Inhaler. | |
US196206A (en) | Improvement in inhalers and respirators | |
DE2803993A1 (en) | Medicament aerosol can audible discharge attachment - consists of two interlocking tubes mounted on operating button and housing vibrating reed | |
CN203777478U (en) | Medicine spraying device for respiratory medicine | |
WO1998007464A1 (en) | Valved aerosol inhalation apparatus with reservoir | |
US780077A (en) | Medical vaporizer. | |
US429321A (en) | Inhaler | |
US491430A (en) | Apparatus for administering medicated vapors | |
US382113A (en) | Inhaler |